Peter Kemlin - RaySearch Laboratories Director Marketing
| RAY-B Stock | SEK 200.00 0.40 0.20% |
Insider
Peter Kemlin is Director Marketing of RaySearch Laboratories AB
| Age | 49 |
| Phone | 46 8 51 05 30 00 |
| Web | https://www.raysearchlabs.com |
RaySearch Laboratories Management Efficiency
RaySearch Laboratories' management efficiency ratios could be used to measure how well RaySearch Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Olof Nord | Biotage AB | 48 | |
| Lars LLB | Biotage AB | 62 | |
| Nina Wallander | CellaVision AB | 49 | |
| Shane Judge | Probi AB | 55 | |
| Anming Gong | Elekta AB | 59 | |
| Urban Strindlov | CellaVision AB | 59 | |
| Raffaella Bombarda | Biotage AB | 49 | |
| Mattias Thorsson | Elekta AB | N/A | |
| Karin Russberg | Vitrolife AB | 54 | |
| James Hoey | Elekta AB | 65 | |
| Gustaf Salford | Elekta AB | 46 | |
| Maths hc | CellaVision AB | 57 | |
| Andy McShea | Probi AB | 53 | |
| Patrik Tolf | Vitrolife AB | 53 | |
| Claus Bisgaard | Vitrolife AB | 46 | |
| Yve Thorenburg | CellaVision AB | 65 | |
| Veronica Dong | Probi AB | N/A | |
| Tomas Blomquist | Biotage AB | 53 | |
| JonSverre Schanche | Biotage AB | 66 | |
| Daniel Forss | Vitrolife AB | 51 | |
| Jonas Bolander | Elekta AB | 57 | |
Management Performance
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 |
RaySearch Laboratories Leadership Team
Elected by the shareholders, the RaySearch Laboratories' board of directors comprises two types of representatives: RaySearch Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RaySearch. The board's role is to monitor RaySearch Laboratories' management team and ensure that shareholders' interests are well served. RaySearch Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RaySearch Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henrik Bergentoft, Chief Officer | ||
| Peter Kemlin, Director Marketing | ||
| Johan Lof, CEO, Founder | ||
| MBA CMD, Pres Americas | ||
| Kjell Eriksson, Head Officer | ||
| Petra Jansson, G Counsel | ||
| Fredrik Lofman, Head Learning |
RaySearch Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RaySearch Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.45 B | |||
| Shares Outstanding | 25.83 M | |||
| Shares Owned By Insiders | 4.00 % | |||
| Shares Owned By Institutions | 55.61 % | |||
| Price To Earning | 56.86 X | |||
| Price To Book | 3.16 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RaySearch Stock Analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.